Community

The Robert Larner, M.D. College of Medicine at the University of Vermont has a remarkable community that provides ample opportunities to connect with fellow graduate students, postdocs, staff, and faculty. Offerings include workshops, conferences, events and seminars to bring together the perspectives of our diverse specialties. It is important to share your voice and feel heard as well as get involved with our Larner Community. 

Calendars of Events

Social Media Connections

SocialMedia.pexels-tracy-le-blanc-607812

UVM Handshake, UVM Connect, LinkedIn, Instagram, Twitter. . . find our social media communities by checking out these social media platforms here

  • UVM Cancer Researcher Frances Carr Elected AAAS Fellow
    February 16, 2022 by Jennifer Nachbur
    Frances Carr, Ph.D., professor of pharmacology at the Larner College of Medicine at the University of Vermont and UVM Cancer Center member, has been elected to the American Association for the Advancement of Science Fellows Class of 2021.
  • Teaching Academy Snow Season Retreat Celebrates Medical Education Excellence
    February 9, 2022 by Jennifer Nachbur
    University of Vermont Larner College of Medicine faculty, leaders, and colleagues gathered virtually for the Teaching Academy’s 2022 Snow Season Education Retreat January 20-21. Highlights of the two-day event included a plenary session by representatives of the Kern National Network for Caring and Character in Medicine, the Induction and Award Ceremony, and an in-person poster session.
  • Davidson Invested as Inaugural Schapiro-Carroll Green and Gold Professor of Anesthesiology
    February 8, 2022 by Jennifer Nachbur
    In a ceremony held February 7, 2022, Melissa Davidson, M.D., a faculty physician leader at the University of Vermont’s Larner College of Medicine, was invested as the inaugural holder of the Howard Schapiro, M.D.’80 and Janet Carroll, M.S.N., M.P.H., Green & Gold Professorship in Anesthesiology.
  • Higgins’ Contingency Management Work in The Guardian Article
    February 8, 2022 by Lucy Gardner Carson
    (FEBRUARY 8, 2022) A contingency management program developed by psychologist Stephen Higgins, Ph.D., professor of psychiatry, to treat patients with addictions was mentioned in The Guardian.
  • UVM Cancer Center Investigators Publish the Breast Pre-Cancer Atlas
    January 18, 2022 by Kate Strotmeyer
    UVM Cancer Center researchers contributed to the establishment of a breast pre-cancer atlas, which establishes the molecular and cellular properties of early-stage breast cancer and is the result of a six-year, National Cancer Institute-funded, collaborative initiative.
  • CVRI Viridis Montis Challenge Highlights Early-Career Researchers
    February 3, 2022 by User Not Found
    Cardiac remodeling, chronic kidney disease, brain cell energy generation, hypertension and stroke risk, and socioeconomic status and cardiac rehabilitation outcomes, were the topics presented at the Cardiovascular Research Institute of Vermont’s annual Viridis Montis Early Career Investigator Challenge on February 2, 2022.
  • Richard Rawson, Ph.D. Receives American Society of Addiction Medicine Presidential Award
    February 3, 2022 by Nicole Twohig
    Richard Rawson, PhD, professor of psychiatry and co-director of the Collaboration, Dissemination, and Education Core at the Vermont Center on Behavior and Health, and senior advisor, best practices core at the University of Vermont Center on Rural Addiction was notified by the American Society of Addiction Medicine (ASAM) that he was chosen to receive the ASAM Presidential Award.
  • Bruce and Despres' Study Sheds Light on COVID-19 Variants' Infectivity
    February 3, 2022 by Jennifer Nachbur
    In a new study in the journal PNAS, a team of University of Vermont and University of Washington scientists discovered that – based on clinical samples from infected individuals – the Delta variant had a higher infectivity than the Alpha variant of COVID-19.
  • R35 Maximizing Investigator's Research Award
    February 2, 2022 by Division of Surgical Research
    Kalev Freeman, MD, associate professor of surgery and pharmacology, received a $1.95 million, five-year R35 Maximizing Investigator’s Research Award from the National Institutes of Health and the National Institute of General Medical Sciences.
    Read full story at FreemanLab
  • Becoming Bat-man
    February 2, 2022 by Division of Surgical Research
    Becoming bat-man: comparative computational modeling between bats and humans to discover bat-inspired treatment for acute viral infections.
    Read full story at MDPI
  • Cipolla Named Chair of Electrical and Biomedical Engineering
    January 31, 2022 by Jennifer Nachbur
    Marilyn Cipolla, Ph.D., professor of neurological sciences at the Larner College of Medicine at the University of Vermont, has been appointed chair of the Department of Electrical and Biomedical Engineering in the UVM College of Engineering and Mathematical Sciences.
  • Psychiatry Researchers Receive Phase 2 HBCD Grant
    January 31, 2022 by Nicole Twohig
    Vermont Center on Behavior and Health investigators were notified that they received a $5.5 million, five-year grant to participate in the Phase II portion of the HEALthy Brain and Child Development (HBCD) Study,
  • Bell Comments on Vermont's Less-Severe COVID Cases in U.S. News Story
    January 28, 2022 by Jennifer Nachbur
    (JANUARY 28, 2022) An article in U.S. News & World Report focused on Vermont's highest-in-the-nation vaccination rates, and included comments from Rebecca Bell, M.D., M.P.H., assistant professor of pediatrics.
  • Foundations Celebration Recognizes Class of '24 Teachers, Staff, & Med Students
    January 27, 2022 by Michelle Bookless & Jennifer Nachbur
    The Larner College of Medicine medical student Class of 2024 celebrated its completion of the Foundations Level of the Vermont Integrated Curriculum with a virtual celebration and awards presentation on January 27, 2022.
  • UVM Health Network President & CEO Brumsted Announces Retirement in September
    January 26, 2022 by Annie Mackin
    After more than four decades as a physician, innovator and national leader in health care, John R. Brumsted, M.D., president and CEO of The University of Vermont Health Network since it was founded in 2011, has announced that he will retire in September 2022.
  • Maija Reblin, Ph.D. appointed co-leader for the UVM Cancer Center’s Cancer Control and Population Health Sciences program
    January 26, 2022 by Kate Strotmeyer
  • Summer Student Research Program Trains Next Generation of Cancer Scientists
    January 26, 2022 by Katherine Strotmeyer
    The UVM Cancer Center Summer Student Fellowships in Cancer Research provide $3,000 stipends to graduate and medical students for cancer-related research projects, overseen by senior faculty members affiliated with the center.
  • Lahey Discusses Omicron Status on WCAX-TV’s ‘You Can Quote Me’
    January 23, 2022 by Lucy Gardner Carson
    (JANUARY 23, 2022) Infectious disease expert Tim Lahey, M.D., M.M.Sc., professor of medicine, was interviewed about the omicron COVID-19 variant for WCAX-TV’s “You Can Quote Me” (YCQM).
  • Wilcox Appointed Associate Dean for Faculty Affairs
    January 19, 2022 by Ed Neuert
    Professor of Pathology and Laboratory Medicine Rebecca Wilcox, M.D., has been appointed associate dean for faculty affairs at the Larner College of Medicine.
  • Bruce Quoted in Nature News Article on Omicron Spread
    January 19, 2022 by Jennifer Nachbur
    (JANUARY 19, 2022) Assistant Professor of Microbiology and Molecular Genetics Emily Bruce, Ph.D., commented on Omicron’s hyper-transmissibility in an article in the News section of the journal Nature.